Nina Weisser PhD

Nina Weisser, Ph.D, is Senior Director of the Multispecific Antibody Therapeutics group at Zymeworks, where she leads a team focused on mechanism of action studies. Since joining Zymeworks, Dr. Weisser has led several multispecific therapeutics research programs, including zanidatamab, from discovery to early development. She received her Ph.D. from the University of Guelph and held a post-doctoral fellowship at the National University of Ireland, Galway.